Weight loss in obesity and overweight Nutritional, Metabolic, Endocrine
Conditions
Interventions
Current intervention as of 24/01/2022:
Following informed consent, participants will be asked to complete online assessments at 0 and 6 months. This will include:
- Self-measured height and weight
- Q
Sponsors
University of Cambridge
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Age >=18 years 2. Completed a weight loss programme in the last 3 months 3. Capable of giving informed consent 4. Have a good understanding of the English language (for the pilot study, materials are not tailored to support non-English language speakers) 5. Willing to be randomised 6. Willing to complete study measurements 7. Able to access the web-based platform from home 8. Who own a set of scales that they can weigh themselves with during the study
Exclusion criteria
Exclusion criteria: 1. Using insulin 2. Previous/planned bariatric surgery 3. Current/planned pregnancy 4. Current diagnosis of eating disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measure as of 24/01/2022: 1. Feasibility and acceptability outcomes: 1.1. Number and characteristics of those invited measured using data from weight management services collected during the recruitment period 1.2. Number and characteristics of the following measured using study database records collected during the recruitment period: 1.2.1. Recruited participants (by recruitment method and by study group) 1.2.2. Respondents (by recruitment method and by study group 1.2.3. Participants who withdraw or have missing data (by study group) 1.3. Recruitment rate (per month, per weight management service, and by study group) measured using study database records collected during the recruitment period 1.4. Proportion of missing data (by outcome measure) measured using study database records collected throughout the study period 1.5. Experience of participants and coaches in terms of participating in, and supporting the delivery of, the study, respectively. measured by qualitative telephone/video interviews conducted at 3 months and 6 months 1.6. Views and experiences of participants who withdraw from the study measured by qualitative telephone/video interviews conducted throughout the study period 2. Outcomes for assessment of effectiveness: 2.1. Clinical outcomes: 2.1.1. Height (cm) measured by self-report at baseline 2.1.2. Weight (kg) measured by self-report at baseline and 6 months 2.2. Quality of Life and Wellbeing: 2.2.1. Health-related quality of life measured using the EQ-5D-5L questionnaire at baseline and 6 months 2.2.2. Capability/Wellbeing measured using the ICEpop CAPability measure for Adults (ICECAP-A) at baseline and 6 months 2.3. Economic Evaluation: 2.3.1. Health/ Social Care Use measured using a bespoke resource use questionnaire at baseline and 6 months 2.3.2. Out of pocket costs measured using a bespoke resource use questionnaire at baseline and 6 months 2.4. Psychosocial factors: 2.4.1. Disinhibition measured using the Thre | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
England, United Kingdom
Outcome results
None listed